Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eaton Vance Ohio Municipal Income Trust (NQ:EVO)

3.440 -0.210 (-5.75%)
Streaming Delayed Price Updated: 12:31 PM EST, Feb 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eaton Vance Ohio Municipal Income Trust

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
Via ACCESS Newswire
News headline image
Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations
Via ACCESS Newswire
News headline image
Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz
Via ACCESS Newswire
News headline image
Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome
Via ACCESS Newswire
News headline image
Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership
Via ACCESS Newswire
News headline image
Earnings Scheduled For November 5, 2025 ↗
 
Via Benzinga
News headline image
An Overview of Evotec's Earnings ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 6, 2025 ↗
 
Via Benzinga
News headline image
Evotec SE Reports 9M 2025 Results: Continued Strong Execution on Strategic Priorities
Via ACCESS Newswire
News headline image
In A Landmark Industry Transaction, Evotec Signs Agreement With Sandoz, Resulting In Payments Potentially Over US $650 M Plus Royalties
Via ACCESS Newswire
News headline image
Evotec SE to Announce Results for The First Nine Months 2025 on 05 November 2025
Via ACCESS Newswire
News headline image
Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb
Via ACCESS Newswire
News headline image
Evotec SE Reports H1 2025 Results: Strong Progress on Strategy Execution
Via ACCESS Newswire
News headline image
Earnings Scheduled For August 13, 2025 ↗
 
Via Benzinga
News headline image
Evotec SE to announce first half-year results 2025 on 13 August 2025
Via ACCESS Newswire
News headline image
Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse Site
Via ACCESS Newswire
News headline image
Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Nasdaq Surges Over 100 Points; Domino's Shares Fall After Q2 Results ↗
 
Via Benzinga
News headline image
Evotec, Webull And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Evotec Adjusts Revenue Guidance and Confirms Profit Guidance Anticipating a More Profitable Revenue Mix
Via ACCESS Newswire
News headline image
Why Block Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Evotec SE Adjusts Revenue Guidance while Confirming Profit Guidance
Via ACCESS Newswire
News headline image
Evotec's Collaboration Sparks Hope For Acute Kidney Injury Breakthroughs ↗
Evotec shares rise after joining NURTuRE-AKI to advance kidney disease research through molecular data integration. 
Via Benzinga
News headline image
Evotec Joins NURTuRE-AKI Consortium to Gain Multi-Omics-Based Molecular Understanding of Acute Kidney Injury
Via ACCESS Newswire
News headline image
DHT Holdings Posts Weak Sales, Joins Compass Diversified, Okta And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.